Skip to content
Recall Observatory FDA recall evidence

Drug product

DOXOrubin Hydrochloride Liposome injection, 50 mg/25 mL (2mg/mL), 25 mL single-dose vials, Sterile, Rx only, Manufactured for: Northstar Rx LLC., Memphis, TN 38141, Manufactured by: Sun Pharmaceutical Ind. Ltd., Halol-Baroda Highway, Halol, Gujarat, India, NDC 72603-200-01.

D-0580-2026

May 12, 2026

Class I

Product summary

Firm
SUN PHARMACEUTICAL INDUSTRIES INC
Event
Event 98921
Status
Ongoing
Classification
Class I
Quantity
675 vials
Official record key
drug-enforcement:D-0580-2026

Official wording

Reason: Presence of Particulate matter: Particulate matter identified as glass.

Code information: Lot HAG2581B, expires: 05/31/2027

Distribution pattern: U.S. Nationwide

Derived failure modes

  • Foreign material or chemical contamination

    reason.foreign_material_chemical_contamination · v1.0.0

    Particulate matter